Beranda › Limfoma Sel-T › Illinois › Chicago
Uji klinis Limfoma Sel-T di Chicago, IL
6 studi untuk Limfoma Sel-T mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Menerima pesertaFase 2
- Northwestern University, Chicago
- University of Illinois, Chicago
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Menerima pesertaFase 3
- North Western University Robert H. Lurie Comprehensive Cancer Center RHLCCC, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Menerima pesertaFase 1/2
- University of Chicago Medical Center, Chicago
A Registry for People With T-cell Lymphoma
Menerima pesertaStudi observasional
- Northwestern Medicine (Data Collection), Chicago
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Menerima pesertaFase 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Uji klinis Limfoma Sel-T di kota lain
- New York City, NY13 studi
- Philadelphia, PA10 studi
- Baldwin Park, CA9 studi
- Boston, MA9 studi
- Houston, TX8 studi
- Atlanta, GA8 studi
- Seattle, WA6 studi
- Columbus, OH6 studi
- Rochester, MN6 studi
- New Haven, CT5 studi
- Miami, FL5 studi
- Ann Arbor, MI4 studi
Studi lain di Chicago
- Kanker Paru Non-Sel Kecil61 studi
- Kanker Payudara58 studi
- Kanker (semua jenis)51 studi
- Kanker Metastatik45 studi
- Kanker Prostat45 studi
- Obesitas41 studi
- Kanker Paru41 studi
- Kanker Ovarium36 studi
- Stroke34 studi
- Kanker Kolorektal33 studi
- Gagal Jantung31 studi
- Kelebihan Berat Badan28 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.